Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Haydon, Rex C.
One or more keywords matched the following items that are connected to
Haydon, Rex C.
Item Type
Name
Concept
High Mobility Group Proteins
Academic Article
Potential use of Sox9 gene therapy for intervertebral degenerative disc disease.
Search Criteria
High Mobility Group Proteins